Venture Capital Investors

OVP Venture Partners

OVP Venture Partners is a VC investing group that helps its portfolio companies by accelerating their success.

Venture Investor Overview

Venture Investor
OVP Venture Partners
Status
InActive
Investor Type
Venture Capital
Activity Level
123 transactions
Funds Raised
Unknown
Industry Focus
Security

Contact Information

Contact
Chad Waite
Title
Managing Director
Mailing Address
1010 Market St.
Kirkland, WA 98033
USA
Phone
(425) 889-9192
Website
www.ovp.com
Email Address
Not Recorded

Background Information

Overview
OVP is the market leader in the Pacific Northwest with over $700 million in committed capital under our management. We originate and lead our investments and focus on firms serving markets such as the network edge and mobility, the corporate data center, imaging and the digital home, bioinformatics and nanotechnology.
Profile
OVP Venture Partners LinkedIn Company Profile
Social Media
OVP Venture Partners Company Twitter Account
Company News
OVP Venture Partners News
Facebook
OVP Venture Partners on Facebook
YouTube
OVP Venture Partners on YouTube
Last Transaction
4/14/2021

Transaction History

Our records indicate that OVP Venture Partners invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
Axiado
4/14/2021
$20,000,000
Group14 Technologies
12/22/2020
$17,000,000
Axiado
12/20/2019
$10,000,000
Group14 Technologies
11/26/2019
$18,000,000
Verdezyne
4/29/2014
$48,000,000
Novomer
12/10/2013
Unknown
NanoString Technologies
12/3/2012
$15,300,000
VLST
9/30/2012
$3,372,000
Adapx
7/30/2012
$3,000,000
Oncofactor
6/30/2012
$1,700,000
Symform
4/25/2012
$11,000,000
DataSphere
3/15/2012
$8,000,000
Genologics Life Sciences Software
2/10/2012
$8,000,000
RedSeal
12/31/2011
$10,000,000
Allozyne
12/23/2011
Unknown
Groove Biopharma
12/12/2011
$6,000,000
Tigo Energy
12/12/2011
$18,000,000
NanoString Technologies
11/7/2011
$20,000,000
Aggregate Knowledge
9/30/2011
$11,300,000
Symform
9/15/2011
$1,000,000
Lucid Commerce
7/29/2011
$8,000,000
Verdezyne
6/30/2011
Unknown
Acylin Therapeutics
6/30/2011
$2,399,900
Scout Analytics
6/30/2011
$3,000,000
Oncofactor
5/25/2011
$2,100,000
Adapx
5/20/2011
$5,000,000
Aggregate Knowledge
3/31/2011
$3,125,100
Collaborative Software Initiative
3/31/2011
$3,713,000
Allozyne
12/31/2010
$1,500,200
Verdezyne
12/31/2010
$6,320,000
Acylin Therapeutics
12/31/2010
$1,999,900
Serus
12/31/2010
$1,000,000
Avenda Systems
12/31/2010
$2,000,000
Novomer
12/31/2010
$4,000,000
CradlePoint
12/14/2010
$7,500,000
CarbonFlow
10/29/2010
$4,200,000
Collaborative Software Initiative
9/30/2010
$750,000
DataSphere
9/9/2010
$10,000,000
Complete Genomics
8/19/2010
$39,000,000
Symform
6/30/2010
$4,000,000
CarbonFlow
6/30/2010
$766,000
Napera Networks Management
6/30/2010
$539,000
XORI
6/30/2010
$2,300,000
Tigo Energy
6/9/2010
$10,000,000
Groove Biopharma
4/26/2010
Unknown
Verdezyne
3/31/2010
$6,039,000
Aggregate Knowledge
1/6/2010
$9,000,000
Symform
12/31/2009
$500,000
Fate Therapeutics
11/16/2009
$30,000,000
RedSeal
10/21/2009
$12,000,000
Complete Genomics
8/24/2009
$45,000,000
Advanced Inquiry Systems
8/18/2009
$11,000,000
Novomer
8/17/2009
$14,000,000
Limerick BioPharma
7/15/2009
$15,000,000
XORI
6/30/2009
$2,101,800
Talyst
6/12/2009
$8,000,000
Nanostream
6/9/2009
$30,000,000
Tigo Energy
6/8/2009
$10,000,000
Symform
4/27/2009
$1,500,000
Adapx
4/12/2009
$9,000,000
Arzeda
2/27/2009
$12,000,000
PharmSelex
12/31/2008
$4,500,000
Collaborative Software Initiative
12/31/2008
$1,500,000
Max-Viz
12/31/2008
$11,362,600
Advanced Inquiry Systems
12/31/2008
$1,200,000
CarbonFlow
11/7/2008
Unknown
EnerG2
11/3/2008
$8,500,000
Napera Networks Management
11/3/2008
$6,000,000
Groove Biopharma
9/30/2008
$3,634,000
Seredigm
9/30/2008
$700,000
Recodagen
9/30/2008
$600,000
DepotPoint
7/21/2008
$7,000,000
GainSpan
6/30/2008
$600,000
Max-Viz
6/30/2008
Unknown
PharmSelex
6/30/2008
$200,000
VLST
6/30/2008
$15,000,000
Fate Therapeutics
6/30/2008
$12,900,000
Lumigent Technologies
6/13/2008
$2,500,000
Tigo Energy
6/3/2008
$6,000,000
Vantos
5/27/2008
$10,690,000
Talyst
5/14/2008
$20,000,000
Plectix BioSystems
3/31/2008
$3,750,000
AdmitOne Security
3/31/2008
$7,499,900
Avenda Systems
3/20/2008
$5,000,000
NDS Surgical Imaging
3/4/2008
$18,000,000
Vantos
12/31/2007
$2,500,000
GainSpan
12/19/2007
$20,000,000
Adapx
12/5/2007
$10,000,000
Fate Therapeutics
11/29/2007
$12,000,000
M2E Power
11/16/2007
$8,000,000
Allozyne
10/26/2007
$30,000,000
Advanced Inquiry Systems
9/30/2007
$8,000,000
Accelerator Alumni
8/3/2007
$22,500,000
Serus
7/11/2007
$8,000,000
Napera Networks Management
6/30/2007
$1,000,000
Virtugo
6/26/2007
$4,000,000
Nanostream
6/22/2007
$8,000,000
Collaborative Software Initiative
4/16/2007
Unknown
Max-Viz
3/31/2007
$1,000,000
Seredigm
3/31/2007
$2,499,900
Complete Genomics
3/31/2007
$13,050,000
GraniteEdge Networks
3/31/2007
$2,500,000
AdmitOne Security
1/10/2007
$11,000,000
Oraya Therapeutics
12/31/2006
$2,000,000
Genologics Life Sciences Software
11/13/2006
$5,500,000
Talyst
11/10/2006
$20,000,000
Emphany Systems
9/30/2006
$13,350,000
Virtugo
7/14/2006
$13,600,000
NDS Surgical Imaging
6/26/2006
$25,500,000
VLST
6/16/2006
$55,000,000
Complete Genomics
5/30/2006
$6,000,000
Applied Identity
5/25/2006
$12,000,000
Airgo Networks
3/31/2006
$20,000,000
Action Engine
3/31/2006
$3,000,000
Max-Viz
3/16/2006
$6,000,000
Nanostream
6/30/2005
$3,900,000
Airgo Networks
6/30/2005
$34,999,900
Plectix BioSystems
6/30/2005
$1,250,000
Theraclone Sciences
3/31/2005
$800,000
SafeHarbor Knowledge Solutions
1/20/2005
$5,000,000
Accelerator Alumni
11/18/2004
$11,800,000
Airgo Networks
2/3/2004
$25,000,000
Airgo Networks
4/29/2003
$20,000,000

 

Investor Contacts

Title
Name
Email & Social
Managing Director
William Funcannon
  William Funcannon LinkedIn Profile  William Funcannon Twitter Account  William Funcannon News  William Funcannon on Facebook
Managing Director
Gerry Langeler
  Gerry Langeler LinkedIn Profile  Gerry Langeler Twitter Account  Gerry Langeler News  Gerry Langeler on Facebook
Managing Director
Chad Waite
  Chad Waite LinkedIn Profile  Chad Waite Twitter Account  Chad Waite News  Chad Waite on Facebook

 

Funds

No fund closings have been recorded for this company.

 

Portfolio Companies

OVP Venture Partners has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company
Accelerator Alumni
Action Engine
Acylin Therapeutics
Adapx
AdmitOne Security
Advanced Inquiry Systems
Aggregate Knowledge
Airgo Networks
Allozyne
Applied Identity
Arzeda
Avenda Systems
Axiado
CarbonFlow
Collaborative Software Initiative
Complete Genomics
CradlePoint
DataSphere
DepotPoint
Emphany Systems
EnerG2
Fate Therapeutics
GainSpan
Genologics Life Sciences Software
GraniteEdge Networks
Groove Biopharma
Group14 Technologies
Limerick BioPharma
Lucid Commerce
Lumigent Technologies
M2E Power
Max-Viz
Nanostream
NanoString Technologies
Napera Networks Management
NDS Surgical Imaging
Novomer
Oncofactor
Oraya Therapeutics
PharmSelex
Plectix BioSystems
Recodagen
RedSeal
SafeHarbor Knowledge Solutions
Scout Analytics
Seredigm
Serus
Symform
Talyst
Theraclone Sciences
Tigo Energy
Vantos
Verdezyne
Virtugo
VLST
XORI

 

 

 

 

Browse more venture capital investors:

Ovo Fund | Owkin

 

Share this article

 

About Our Venture Capital Investor Database

Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.